About NJ Bio
NJ Bio is a Healthcare company based in North Brunswick (United States) founded in 2018, and was acquired by Suven Pharmaceuticals in December 2024. Clinical development services are provided for biotechnology applications. NJ Bio has completed 1 acquisition, including L2P Research Labs. Its website njbio.com draws about 11 thousand monthly visits. NJ Bio offers products and services including ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and Oligonucleotide Services. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Chemical Proteomics. Its legal entity is NJ BIO, INC. Its competitors include Liberation Labs, Seranova and Peplib; 3 of its 3 listed competitors have raised funding.
Company details
NJ Bio was founded in 2018 and is based in North Brunswick, United States. Clinical development services are offered by the company within the biotechnology sector. Operations focus on supporting drug development processes, including trial management and regulatory compliance. Expertise is applied to assist clients in advancing therapeutic candidates from preclinical stages through clinical trials. The firms activities are centered in the U.S., serving pharmaceutical and biotech partners.
- Investors
- Investments & Acquisitions
- Acquired bySuven Pharmaceuticals
(Dec 2024)
Products & Services of NJ Bio
NJ Bio offers a comprehensive portfolio of products and services, including ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and Oligonucleotide Services.
Specialized services for antibody-drug conjugate design and production
Custom manufacturing of biopharmaceutical compounds and linkers
Processes for linking payloads to antibodies in drug development
Analytical testing for drug efficacy and safety assessments
Synthesis and analysis of oligonucleotides for research needs
Development and production of mRNA-based therapeutic components
Custom synthesis of medicinal compounds for drug discovery
Apps and channels of NJ Bio
its YouTube channel NJ Bio, Inc. has 15 subscribers and 1 videos.
Videos from NJ Bio
The most watched videos on NJ Bio's YouTube channel, NJ Bio, Inc. (15 subscribers). Click a video to play it here.
More on NJ Bio, Inc..
Investors in NJ Bio
NJ Bio has secured backing from 1 investor. Prominent investors backing the company include Suven Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Contract manufacturing and development of APIs and formulations are provided. | 1989 | suvenpharm.com | Hyderabad, India |
Investor details for NJ Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NJ Bio
46 people are tracked at NJ Bio (12 in leadership, 6 in board & advisors, 28 in team).
| Name | Role | Group |
|---|---|---|
Timothy Lex | Director, GMP Process Development & Manufacturing | Leadership |
Felicia Shelburne | Director, Human Resources | Leadership |
Nareshkumar Jain | President, CEO & Chairman | Leadership |
Allan Prior | Senior Director, Chemistry | Leadership |
Seungyong Sean Choi | VP of Process R&D, Chemistry | Leadership |
Thomas Markotan | Head of EHS & Project Management | Leadership |
Julien Dugal-Tessier | Director of Innovative Chemistry & Bioconjugation | Leadership |
Arpit Pokharna | Executive Director | Leadership |
Seung-Yong Choi | VP Of Process R&d | Leadership |
Suresh Anaganti | Vice President In Vivo & Translational Research | Leadership |
Avi Dixit | Director Of Business Development | Leadership |
Samson Gebretnsae | Director, Bioconjugation | Leadership |
Ronald Gold | Director | Board & advisors |
Priya Nayak | Director | Board & advisors |
Ravi Chari | Scientific Advisor | Board & advisors |
Zhihua Sui | Scientific Advisor | Board & advisors |
Chetan Jain | Director | Board & advisors |
Rakesh Dixit | Scientific Advisor | Board & advisors |
Ralf Mueller | CBO | Team |
Rupa Sarkar | Principal Scientist | Team |
26 more people are available in the full profile.
Complete people profiles for NJ Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NJ Bio
NJ Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include L2P Research Labs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
L2P Research Labs is engaged in clinical and non-clinical research. | l2plabs.com | Stony Brook, United States | 2015 | Nov 2025 | •••• |
Complete acquisition details for NJ Bio
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NJ Bio
3 dated milestones of NJ Bio across 7 years, from founding to its latest funding, stage changes and deals.
- Founded NJ Bio is founded.
- Exit Acquired by Suven Pharmaceuticals.
- Acquisition Acquires L2P Research Labs.
Competitors of NJ Bio
NJ Bio has 3 listed competitors in our database, 3 of them funded. They include Liberation Labs, Seranova and Peplib.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| liberationlabs.com | 2022 | New York, United States | $107.61M | Fermentation products are manufactured and commercialized via CRO services. | ||
| seranovabio.com | 2020 | New Haven, United States | $10M | CRO offering chemical proteomics services for preclinical development of drug | ||
| peplib.com | 2017 | Boston, United States | $34.22M | Provider of peptide drug discovery and development services for global pharmaceutical industries |
Detailed competitors of NJ Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NJ Bio
The website of NJ Bio (njbio.com) receives about 11.1K visits a month.
- Monthly visits11.1K
▲ 32% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as NJ Bio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nj Bio
Complete news archive for NJ Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NJ Bio
NJ Bio was founded in 2018.
NJ Bio is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
NJ Bio was founded in 2018 and is based in North Brunswick, United States. Clinical development services are offered by the company within the biotechnology sector. Operations focus on supporting drug development processes, including trial management and regulatory compliance. Expertise is applied to assist clients in advancing therapeutic candidates from preclinical stages through clinical trials. The firms activities are centered in the U.S., serving pharmaceutical and biotech partners.
NJ Bio's top competitors include Liberation Labs, Peplib and Seranova.
NJ Bio offers ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and 3 more products and services.
NJ Bio has made 1 acquisition, including L2P Research Labs.
NJ Bio has 1 investor. Key investors include Suven Pharma.
NJ Bio operates through Nj Bio, Inc.
Yes. NJ Bio was acquired by Suven Pharmaceuticals in December 2024.